Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
Annals of the Rheumatic Diseases · 2025-04 · 84 (4) · 653-656
DOI: 10.1016/j.ard.2025.01.043 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annals of the Rheumatic Diseases, 2025-04. Verfasst von Elise Siegert und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Un…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: Horizon 2020, European Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Rheumatology Research Cen…
- Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Department of Infectious Diseases, Respiratory and Critical Care Medicine, Charité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Department of Radiology, Charité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Center for Interdisciplinary Rheumatology, Immunology and Autoimmune Diseases (INDIRA) and Department for Internal Medicine II (Hematology, Oncology, Rheumatology and Immunology), Universitätsklinikum Tübingen, Tübingen…
Förderung
- Horizon 2020
- European Commission
Zitieren
APA
Siegert, E., Biesen, R., Dzamukova, M., Furth, C., Probst, M., Doellinger, F., Walter-Rittel, T., Fleischmann, A., Wilhelm, A., Beenken, A. E., Wiebe, E., Pecher, A. C., Henes, J., Florian, S., Simon, D., Kleyer, A., Burmester, G. R., Keller, U., Krönke, J., …, & Alexander, T. (2025). Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation. Annals of the Rheumatic Diseases, 84(4), 653-656. https://doi.org/10.1016/j.ard.2025.01.043
Vancouver
Siegert E, Biesen R, Dzamukova M, Furth C, Probst M, Doellinger F, et al. Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation. Annals of the Rheumatic Diseases. 2025;84(4):653-656. doi:10.1016/j.ard.2025.01.043
BibTeX
@article{Siegert2025,
author = {Siegert, Elise and Biesen, Robert and Dzamukova, Maria and Furth, Christian and Probst, Meike and Doellinger, Felix and Walter-Rittel, Thula and Fleischmann, Anja and Wilhelm, Artur and Beenken, Anne Elisabeth and Wiebe, Edgar and Pecher, Ann-Christin and Henes, Jörg and Florian, Stefan and Simon, David and Kleyer, Arnd and Burmester, Gerd-Rüdiger and Keller, Ulrich and Krönke, Jan and Krönke, Gerhard and Alexander, Tobias},
title = {Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
volume = {84},
number = {4},
pages = {653--656},
doi = {10.1016/j.ard.2025.01.043}
}
EUVIMED